Seed Investments
Building and investing in biotech from seed to success
What we do
We drive innovation in life sciences by identifying, building, and investing in transformative biotech startups. Leveraging the capabilities of our in-house SeedLab and our robust network of Entrepreneurs-in-Residence (EiRs), we focus on creating and nurturing companies to transform promising science into impactful therapeutic focused biotech companies.
For more insights and the stories behind our portfolio, visit our 'de novo' blog.
Our Approach
Building and Investing in New Companies
We partner with visionary scientists and entrepreneurs to build and invest in new companies, driving them from seed to success with our strategic support and resources.
“Through our hands-on approach, we ensure that promising projects and startup companies have the optimal conditions for success.”
Søren Møller,
Managing Partner, Seed Investments
We provide capital, network and know-how to transform promising life-science discoveries into successful biotech startups.
We focus on company creation and building biotech startups in the Nordic region. Seed Investments aims to develop strong and competitive companies that we finance all the way to a commercial exit.
By the end of 2024, Seeds Investments’ portfolio comprised of 35 companies. Most of the portfolio consists of private investments, valued at DKK 4.2 billion at year end, 19% higher than at the end of 2023.
Seed Investments key figures
DKK4.2 bn
Value of Investments Assets portfolio by the end of 2024
35
Number of portfolio companies
€ 200m
Deployed in 2023
Our Seed Investments Portfolio
Search
Meet our team